Which are the causes of Rothmund-Thomson Syndrome?

TL;DR: Rothmund-Thomson syndrome (RTS) is a rare genetic disorder primarily caused by mutations in the RECQL4 gene, which plays a critical role in DNA repair and genomic stability. Because it is inherited in an autosomal recessive pattern, individuals must inherit a mutated copy of the gene from both parents to develop the condition.

What causes Rothmund-Thomson syndrome at the genetic level?

The primary cause of Rothmund-Thomson syndrome is a mutation in the RECQL4 gene, located on chromosome 8. This gene provides instructions for producing a protein that acts as a "molecular mechanic," helping to repair damaged DNA and maintain the integrity of our genetic blueprint. When this protein is dysfunctional, cells struggle to repair DNA damage, leading to the characteristic features of Rothmund-Thomson syndrome, such as skin abnormalities and an increased risk of certain cancers.

Is Rothmund-Thomson syndrome hereditary?

Yes, Rothmund-Thomson syndrome is inherited in an autosomal recessive manner. This means that for a child to be born with the syndrome, both parents must be carriers of a mutation in the RECQL4 gene, even if the parents themselves do not show symptoms. In cases where the RECQL4 gene is not involved, the condition is classified as Type II Rothmund-Thomson syndrome, though the underlying genetic mechanisms for non-RECQL4 cases remain under active investigation.

Are there different types or causes of the syndrome?

Researchers categorize Rothmund-Thomson syndrome into two main clinical types based on genetic findings:

• Type I: Characterized by poikiloderma (a specific pattern of skin discoloration), sparse hair, and juvenile cataracts; the genetic cause is often linked to RECQL4 mutations.


• Type II: Presents with the same skin symptoms but is more strongly associated with skeletal abnormalities and a significantly higher risk of osteosarcoma.

What is the current status of research into the etiology?

While the role of RECQL4 in Rothmund-Thomson syndrome is well-established, scientists are still studying why the clinical presentation varies so significantly between patients. Current research focuses on how these DNA repair defects trigger premature aging pathways and malignant cell transformation. Understanding these mechanisms is vital for developing targeted therapies for the Rothmund-Thomson syndrome community, including the 2 members currently sharing their experiences on DiseaseMaps.org.

Next steps

• Consult with a clinical geneticist to discuss genetic testing and family counseling.


• Schedule regular dermatological and orthopedic screenings to monitor for syndrome-related complications.


• Connect with the Rothmund-Thomson syndrome community at DiseaseMaps.org to share resources and support.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Rothmund-Thomson syndrome.


• Orphanet: Rare disease database entry for Rothmund-Thomson syndrome.


• Online Mendelian Inheritance in Man (OMIM): RECQL4 gene and clinical association.


• Rothmund-Thomson Syndrome Foundation: Patient education and research updates.